preview
    From £145.00
    • Effectiveness: Avg. ~22% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Tirzepatide
    preview
    From £159.99
    • Effectiveness: Avg. ~15% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Semaglutide
    preview
    From £194.99
    • Injectable diabetes management medication
    • Not licensed for weight loss in the UK
    • Lowers the risk of cardiovascular conditions
    preview
    From £98.39
    • Effectiveness: Avg. ~10% weight loss*
    • Dose: One daily single dose (4 pens per month)
    • Contains Liraglutide
    Weight Loss
    Updated at: November 26, 20247 min read

    Mounjaro Shortage UK: Explaining the Short Supply of the Weight Loss Injection Pen

    Update: At the time of writing there was a short supply of this medication. Please note that supply may have changed since. For the latest information please refer to the manufacturer website.

    Are you currently a weight loss patient who has been prescribed Mounjaro? If so, we have some important updates to share regarding the weight loss injection. 

    Mounjaro Shortage 2024

    Currently, there's a global shortage of glucagon-like peptide receptor agonists (GLP-1 RAs) like Mounjaro (Bloomberg UK, 2024; Reuters, 2024). But don't worry, UK Meds are on hand to guide you through it.

    Key Takeaways

    Increased Demand is Driving the Shortage

    A global surge in demand for GLP-1 receptor agonists like Mounjaro (tirzepatide), spurred by its effectiveness for weight loss and diabetes management, has led to supply challenges. Media coverage and shortages of alternatives like Wegovy and Ozempic have further increased demand for Mounjaro.

    Support and Alternatives are Available

    If you're affected by the shortage, UK Meds can guide you through alternative treatment options or management plans. Consult your healthcare provider to discuss suitable substitutes tailored to your needs while staying informed about updates from the manufacturer.

    Stopping Treatment is Safe, but Maintenance is Key

    Stopping Mounjaro won’t cause withdrawal symptoms or side effects, but weight regain is possible without lifestyle changes. Sustaining weight loss through balanced eating, regular exercise, proper hydration, and goal-setting can help maintain progress during treatment gaps. Always consult your doctor for personalised advice.

    Mounjaro Shortage UK

    Why is there a shortage of Mounjaro?

    Increased Demand

    The shortage is due in part to the increased demand for the drug semaglutide, known by its brand names Ozempic and Wegovy (both now available in the UK), which has led to shortages of these medications, leading patients to search for alternative diabetes and obesity treatments such as Mounjaro (tirzepatide) and Saxenda (liraglutide)

    Media Coverage

    Thanks to widespread media coverage, more people are discovering the benefits of GLP-1 RA treatments for weight loss. 

    As a result, many are turning to Mounjaro (tirzepatide), and this sudden surge in demand has outpaced the supply (Diabetes UK, 2024).

    When will the supply issues improve?

    An Update from Eli Lilly and Company

    Eli Lilly and Company, the company behind Mounjaro (tirzepatide), has said that Mounjaro supply chain challenges may persist through 2024.

    Update as of 31/10/2024:

    The global shortage situation for Mounjaro is improving as of the latest update by manufacturer Eli Lilly:

    There are currently no shortages in place for Mounjaro in the multi-use KwikPen presentation. The vial presentation of Mounjaro is unavailable except in the 5mg dose (1). Information on supply of Mounjaro vials is available on the Therapeutic Goods Administration TGA medicines shortage reports database.

    Lilly is committed to ongoing replenishment of all doses of the Mounjaro KwikPen presentation. As part of our commitment to supplying Mounjaro in Australia, Lilly continues to invest and add manufacturing capacity around the world. We have commenced incretin production at our manufacturing facility in North Carolina, in the U.S., with additional actions and expansions at other sites around the globe.

    Eli Lilly

    We're actively collaborating with Eli Lilly and Company to secure more stock for our patients and are doing all we can to ensure a continuous supply of medication for those patients who need it. 

    Which drugs are impacted by the short supply of GLP-1 RA medications?

    The current shortages are expected to impact the availability of all GLP-1 RA medications, including:

    • Saxenda

    • Ozempic

    • Wegovy

    • Byetta

    • Victoza

    • Trulicity

    • Bydureon

    • Rybelsus

    What can I do if the Mounjaro shortage affects me?

    If you're a Mounjaro user and the shortage affects you, don't worry; UK Meds is here to support you. You can still complete an online weight loss consultation with us as you would normally. However, due to the shortages, it might be necessary to consider a different weight loss medication or management plan.

    Consult your doctor or healthcare professional to discuss your options prior to starting any treatment as they can advise you on the most appropriate medication for your individual requirements. 

    Stay informed by signing up for email alerts, and rest assured that UK Meds is doing all we can to ensure a constant supply of all medications that our patients need.

    If you have any questions or need assistance, please reach out to the UK Meds team. Your well-being is our priority.

    Mounjaro Shortage FAQs

    Our customers have been in touch asking some common questions about the Mounjaro shortage, including:

    Should I reduce the dose of Mounjaro I take to make it last longer?

    We would recommend taking the dose of the Mounjaro injection that your prescriber recommended. Consult your doctor or healthcare provider if you are unsure about the most appropriate dose of Mounjaro to take.

    Does stopping Mounjaro treatment suddenly cause any side effects?

    Stopping treatment with Mounjaro weight loss injections suddenly will not cause any side effects, so you shouldn’t worry if you find that you’ve run out of your supply of the medication. Mounjaro is not an addictive medication so you will not experience withdrawal symptoms. You should consult your healthcare provider or doctor if your supply of Mounjaro has run out and you require a suitable alternative weight loss treatment.

    Should I expect the price of Mounjaro to change whilst there is a shorter supply of the medication?

    Yes, during this time, the price of Mounjaro may change based on the supply of the medication available in the market currently. UK Meds customers can rest assured that we are doing everything we can to ensure that you receive a fair price.

    Will I put weight back on if I stop taking Mounjaro?

    If you don't actively take steps to maintain your weight loss you may regain weight that you have lost since starting treatment with Mounjaro. Simple lifestyle choices can help you to sustain weight loss including:

    It is important to note that the above are only suggestions and that not all strategies will be appropriate for you. Your doctor will be able to advise you on the best way to lose weight sustainably and safely for your individual needs.

    Medically Reviewed by:
    Dr. Alexis Missick MBChB. MRCGP
    GMC reference no: 7151419
    LinkedIn
    Website

    Sources

    Related Products

    preview
    From £145.00
    • Effectiveness: Avg. ~22% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Tirzepatide
    preview
    From £159.99
    • Effectiveness: Avg. ~15% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Semaglutide
    preview
    From £194.99
    • Injectable diabetes management medication
    • Not licensed for weight loss in the UK
    • Lowers the risk of cardiovascular conditions

    Related Products

    preview
    From £145.00
    • Effectiveness: Avg. ~22% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Tirzepatide
    preview
    From £159.99
    • Effectiveness: Avg. ~15% weight loss*
    • Dose: One weekly single dose (One pen per month)
    • Contains Semaglutide
    preview
    From £194.99
    • Injectable diabetes management medication
    • Not licensed for weight loss in the UK
    • Lowers the risk of cardiovascular conditions

    Blog author

    Scott Weaver

    Scott is an experienced and professional content writer who works exclusively for UK Meds.

    Here to help you

    Our Customer Service is available Monday to Friday 9am - 5pm. If you need urgent assistance, do not use this service. Call 111, or in an emergency call 999. Visit our help section